---
$id: https://graph.org.ai/products/commodity/51182205
$type: Product
source: UNSPSC
code: "51182205"
title: "Doxaprost"
class: "51182200"
classTitle: "Drugs for inducing labor"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Doxaprost

**UNSPSC Code**: 51182205
**Class**: [Drugs for inducing labor](Drugs for inducing labor.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue with the molecular formula C21H36O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W3G873MK03, chemically known as prost-13-en-1-oic acid, 15-hydroxy-15-methyl-9-oxo-, (13e) but generally known as doxaprost, which bears US NIH Compound Identifier 6441612. European Medicines Agency schedules Doxaprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06383MIG. The term DOXAPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). DOXAPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doxaprost under HS 29375000 and SITC 54156. As of Q4 2014, DOXAPROST remains the US FDA Preferred Term for this commodity. Doxaprost bears US NLM identifiers UMLS ID C2699807 and NCI Concept Code C74370. SMILES: O=C1C(C(CC1)/C=C/C(O)(CCCCC)C)CCCCCCC(=O)O.

